Pfizer and German partner BioNTech said on Thursday that their vaccine to prevent flu and COVID-19 generated a strong immune response against strains of the viruses in an early- to mid-stage trial. The companies said they plan to start a late-stage trial in the coming...
Pfizer and German partner BioNTech said on Thursday that their vaccine to prevent flu and COVID-19 generated a strong immune response against strains of the viruses in an early- to mid-stage trial."This vaccine has the potential to lessen the impact of two respiratory diseases with a single injection and may simplify immunization practices," Annaliesa Anderson, Pfizer's head of vaccine research and development, said in a statement.
In the trial, the vaccine candidates were compared to a licensed influenza vaccine and the companies' updated COVID-19 vaccine given at the same visit. The data from the trial showed that the flu-COVID vaccine demonstrated robust immune responses to influenza A, influenza B and SARS-CoV-2 strains, the companies said.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Getting flu and COVID shot together still reasonable amid safety review of potential stroke risk: ExpertsExperts urged results were preliminary and may be explained by other factors.
Read more »
Pfizer's combination Covid, flu vaccine will move to final-stage trial after positive dataPfizer, Moderna and Novavax believe combination shots will simplify the process for people to protect themselves against Covid and the flu.
Read more »
Pfizer's combination Covid, flu vaccine will move to final-stage trial after positive dataPfizer, Moderna and Novavax believe combination shots will simplify the process for people to protect themselves against Covid and the flu.
Read more »
‘On track’: Three percent of Americans have gotten the new Covid shot, but the CDC director remains confidentBy contrast, nearly 39 percent have had their flu shot.
Read more »
A new shot for RSV shot for infants is in short supplyA new shot for infants against RSV is in short supply, and U.S. health officials are telling doctors they should prioritize giving the drug to babies at the highest risk of severe disease
Read more »
A new shot for RSV shot for infants is in short supplyA new shot for infants against RSV is in short supply, and U.S. health officials told doctors they should prioritize giving the drug to babies at the highest risk of severe disease.
Read more »